Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Wheaton Precious Metals Corp (WPM) Price & Performance

Eli Lilly And CoTrade
Wheaton Precious Metals CorpTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Wheaton Precious Metals Corp — how do they compare? Eli Lilly And Co trades at $1,162.9 (market cap $1.02T), while Wheaton Precious Metals Corp trades at $109.9 (market cap $46.54B). The key difference: Eli Lilly And Co is far larger — about 21.9× Wheaton Precious Metals Corp's market cap, and Wheaton Precious Metals Corp pays the higher dividend (0.75%). Which is the better fit depends on your goals.

LLYWPM
Market Cap
$1.02T$46.54B
Sector
HealthBasic Materials
52-Week High
$1.24K$165.72
52-Week Low
$625.65$91.00
Enterprise Value
$1.06T$44.39B
Dividend Yield
0.6%0.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

Wheaton Precious Metals Corp

Wheaton Precious Metals (WPM) trades at $103.81, down 0.36% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.28 exceeding the $1.24 estimate. Revenue surged to $2.31 billion in 2025, driving a net income margin of 63.58%. Operating cash flow reached a record $1.90 billion, supporting a positive net cash flow of $335.43 million. Analyst consensus remains strongly bullish with an 80% buy rating and a $161.75 price target, indicating significant upside potential.

WPM presents a compelling investment case based on robust fundamentals and strong analyst support, though technical indicators suggest near-term caution. Key opportunities include sustained earnings growth, high profit margins, and a solid cash flow outlook. Risks involve exposure to precious metal price volatility, geopolitical tensions impacting mining operations, and potential valuation compression if silver prices remain subdued. The stock's current price offers an attractive entry point relative to analyst targets, but investors should monitor commodity market trends and quarterly performance closely.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Wheaton Precious Metals Corp

Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.

Read more on WPM